Onyx Sciences is an early-stage BioTech and MedTech studio.
We validate and commercialize patent-protected assets from world-leading research institutions.
Commercial thesis:
Personal network and the following core tenets enable Onyx Sciences to license IP affordably and complete robust proof-of-concept validation studies.
Elite IP access
Assets are networked from blue chip institutions and investigators at the top 1% of their field.
Non-invasive
Our devices don’t pierce the skin barrier, reducing validation costs and expediting regulatory path.
Patent-protected
Institutionally-owned WIPO PCT, USPTO patented assets. Early in patent life, broad in coverage.
Market-focused
Indications selected with input from a deep bench of clinicians and device industry veterans.
Material-efficient
Bias toward assets with low manufacturing complexity and safe predicate materials.